Dennis Kim, MD, MBA.

Dr. Dennis Kim, President and CEO of
Xeno Biosciences, is an endocrinologist and specializes in
metabolic diseases. He has held senior roles at CymaBay, Orexigen,
and Amylin Pharmaceuticals, where he led the development of
Byetta® for type 2 diabetes.